Literature DB >> 7134033

Partial structure of a large canine cholecystokinin (CCK58): amino acid sequence.

V E Eysselein, J R Reeve, J E Shively, D Hawke, J H Walsh.   

Abstract

A cholecystokinin molecule larger than any previously chemically characterized was purified from canine proximal small intestine mucosa. The purification procedure consisted of sequential steps of affinity chromatography, gel filtration, and high pressure liquid chromatography. Activity was detected and quantitated by radioimmunoassay with an antibody that recognized the carboxyl terminal sequence of porcine cholecystokinin. Microsequencing of the purified peptide revealed an amino terminal nonadecapeptide sequence (AQKVNSGEPRAHLGALLAR) not present in known cholecystokinin molecules followed by a nonadecapeptide sequence (YIQQARKAPSGRMSVIKNL) that corresponds exactly to the amino terminal sequence of porcine cholecystokinin 39 except for reversed positions of a Met and a Val residue. Based on the sequence analysis, immunoreactivity, and presence of biological activity in two bioassay systems, this peptide, tentatively named cholecystokinin 58, may be a biosynthetic precursor of the smaller forms previously characterized in gastrointestinal and brain tissues.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7134033     DOI: 10.1016/0196-9781(82)90171-1

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  10 in total

1.  Cloning and sequence analysis of a cDNA encoding rat preprocholecystokinin.

Authors:  R J Deschenes; L J Lorenz; R S Haun; B A Roos; K J Collier; J E Dixon
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

2.  Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, and relationship to gallbladder contraction.

Authors:  R A Liddle; I D Goldfine; M S Rosen; R A Taplitz; J A Williams
Journal:  J Clin Invest       Date:  1985-04       Impact factor: 14.808

3.  CCK-58 elicits both satiety and satiation in rats while CCK-8 elicits only satiation.

Authors:  Joost Overduin; James Gibbs; David E Cummings; Joseph R Reeve
Journal:  Peptides       Date:  2014-01-24       Impact factor: 3.750

4.  Differential expression of the mouse cholecystokinin gene during brain and gut development.

Authors:  J Friedman; B S Schneider; D Powell
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

5.  Isolation of a large cholecystokinin precursor from canine brain.

Authors:  V E Eysselein; J R Reeve; J E Shively; C Miller; J H Walsh
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

6.  Molecular cloning of the human cholecystokinin gene by use of a synthetic probe containing deoxyinosine.

Authors:  Y Takahashi; K Kato; Y Hayashizaki; T Wakabayashi; E Ohtsuka; S Matsuki; M Ikehara; K Matsubara
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

7.  Physiological role for cholecystokinin in reducing postprandial hyperglycemia in humans.

Authors:  R A Liddle; R J Rushakoff; E T Morita; L Beccaria; J D Carter; I D Goldfine
Journal:  J Clin Invest       Date:  1988-06       Impact factor: 14.808

8.  Total synthesis, purification, and characterization of human [Phe(p-CH2SO 3Na)52, Nle32,53,56, Nal55]-CCK20-58, [Tyr52, Nle32,53,56, Nal55]-CCK-58, and [Phe(p-CH2SO3Na)52, Nle32,53,56, Nal55]-CCK-58.

Authors:  M T Miranda; A G Craig; C Miller; R A Liddle; J E Rivier
Journal:  J Protein Chem       Date:  1993-10

9.  Pig brain contains cholecystokinin octapeptide and several cholecystokinin desoctapeptides.

Authors:  J Eng; Y Shiina; Y C Pan; R Blacher; M Chang; S Stein; R S Yalow
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

10.  Bile acids in human plasma interfere with cholecystokinin bioassay using dispersed pancreatic acini.

Authors:  K Miyasaka; A Funakoshi; M Matsumoto; R Nakamura; S Sakamoto; H Sakai; K Kitani
Journal:  Dig Dis Sci       Date:  1991-03       Impact factor: 3.199

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.